Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjoern Harder

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Ophthalmology|November 15, 2006
Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusionJost B Jonas, Bjoern Harder
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 5, 2006
Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathyJost B Jonas, Ulrich H Spandau, Bjoern Harder, et al.
American Journal of Ophthalmology|February 24, 2006
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideJost B Jonas, Ingrid Kreissig, Ulrich H Spandau, et al.
Ophthalmic Research|October 19, 2006
Repeated intravitreal injection of triamcinolone for exudative age-related macular degenerationJost B Jonas, Ulrich H Spandau, Bernd A Kamppeter, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 2, 2006
Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degenerationJost B Jonas, Vanessa Strueven, Bernd A Kamppeter, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 1, 2006
Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized studyJost B Jonas, Bernd A Kamppeter, Bjoern Harder, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 17, 2006
Triamcinolone acetonide-induced ocular hypertensionJost B Jonas, Gangolf Sauder, Wido M Budde, et al.
Ophthalmic Research|October 14, 2008
Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degenerationJost B Jonas, Anna K Ihloff, Bjoern Harder, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Ophthalmology|November 15, 2006
Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusionJost B Jonas, Bjoern Harder
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 5, 2006
Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathyJost B Jonas, Ulrich H Spandau, Bjoern Harder, et al.
American Journal of Ophthalmology|February 24, 2006
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideJost B Jonas, Ingrid Kreissig, Ulrich H Spandau, et al.
Ophthalmic Research|October 19, 2006
Repeated intravitreal injection of triamcinolone for exudative age-related macular degenerationJost B Jonas, Ulrich H Spandau, Bernd A Kamppeter, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 2, 2006
Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degenerationJost B Jonas, Vanessa Strueven, Bernd A Kamppeter, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 1, 2006
Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized studyJost B Jonas, Bernd A Kamppeter, Bjoern Harder, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 17, 2006
Triamcinolone acetonide-induced ocular hypertensionJost B Jonas, Gangolf Sauder, Wido M Budde, et al.
Ophthalmic Research|October 14, 2008
Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degenerationJost B Jonas, Anna K Ihloff, Bjoern Harder, et al.
Pageof 1